Our Offering
Biologics
Mammalian
Microbial
ADCs / Bioconjugates
Drug Product
mRNA / LNP
Expression Technologies
Small Molecules
Drug Substance (API)
Particle Engineering
Drug Product
Cell & Gene
Process Development
cGMP manufacturing
Allogeneic
Autologous
Viral Vectors
Bioscience Products
Capsules & Health Ingredients
Pharmaceutical Solutions
Nutraceutical Solutions
Our Company
About Us
Purpose and Strategy
Leadership
History
Locations
Partnering with Us
Events
News and Media
News Archive
Media Library
Logo Guidelines
Blog
Podcast
Media Inquiries
Investor Relations
Shareholder Information
Agenda and Events
Financial Reporting
Annual Report
Corporate Governance
Ethics and Compliance
Investor Inquiries
Sustainability
Performance
People
Planet
Community
Global Quality
Responsible Sourcing
Careers
Overview
Life at Lonza
What We Offer
Career Stories
Job Search
Join Our Talent Community
Recruitment Process
Students, Graduates and Apprentices
Contact
Trending Topics
Webinar: Process Intensification to Improve the Efficiency and Productivity of Biologics Manufacturing
Whitepaper Continuous bioprocessing control and connectivity
CMC Solutions To Meet The Product-Specific Needs of Novel Molecular Biologic Formats
Shaped Around You - Committed to your molecule’s IND
Trending Topics
Webinar: Process Intensification to Improve the Efficiency and Productivity of Biologics Manufacturing
Whitepaper Continuous bioprocessing control and connectivity
CMC Solutions To Meet The Product-Specific Needs of Novel Molecular Biologic Formats
Shaped Around You - Committed to your molecule’s IND
Our Offering
Corporate
Biologics
Mammalian
Microbial
ADCs / Bioconjugates
Drug Product
mRNA / LNP
Expression Technologies
Small Molecules
Drug Substance (API)
Particle Engineering
Drug Product
Cell & Gene
Process Development
cGMP manufacturing
Allogeneic
Autologous
Viral Vectors
Bioscience Products
Capsules & Health Ingredients
Pharmaceutical Solutions
Nutraceutical Solutions
Our Company
Corporate
About Us
Purpose and Strategy
Leadership
History
Locations
Partnering with Us
Events
News and Media
News Archive
Media Library
Logo Guidelines
Blog
Podcast
Media Inquiries
Investor Relations
Shareholder Information
Agenda and Events
Financial Reporting
Annual Report
Corporate Governance
Ethics and Compliance
Investor Inquiries
Sustainability
Performance
People
Planet
Community
Global Quality
Responsible Sourcing
Careers
Corporate
Overview
Life at Lonza
What We Offer
Career Stories
Job Search
Join Our Talent Community
Recruitment Process
Students, Graduates and Apprentices
Contact
Corporate
Home
Knowledge Center
Tools for Developing Successful Biologics - XS Pichia® Expression System
Tools for Developing Successful Biologics - XS Pichia® Expression System
08 Sep 2023 | Content Type: Article
by
Nikolay Krumov, Ph.D.
,
Joachim Klein, Ph.D.
Lonza subject matter experts talk about the XS®
Pichia
Expression System and how it could benefit challenges with biotherapeutic expression.
Download Article
Latest content
Latest briefing from the Knowledge Center
Whitepaper/Executive Summary
Reducing Wastewater Incineration and Carbon Emission
As the pharmaceutical industry works to develop more sustainable processes for large-scale drug...
Video
The CDMO Value Proposition of Experience for Your Autologous Cell Therapy
bluebird bio and Lonza take the opening plenary stage at the CAR-TCR Summit to tell the story of...
Whitepaper/Executive Summary
Overcome Challenges And Secure Successful Technology Transfers Of Complex Biological Products In...
A critical area to consider in selecting a CDMO is their ability to successfully complete technology...
Article
How to Accelerate Your Biotherapeutics' Path to Clinic
Over the last few decades, many novel biotherapeutics have undergone clinical trial testing in the...
Article
Addressing Challenges with Clinical In-Use Testing of Biotherapeutics
The goal of in-use testing of biotherapeutics is to ensure acceptable product quality during dose...
Peer-reviewed publication
Automated production of gene-modified chimeric antigen receptor T cells using the Cocoon® Platform
Abstract: Autologous cell-based therapeutics have gained increasing attention in recent years...
Article
Strategies to Optimize Expression Challenges of Multi-chain and Bispecific Antibodies
Many of today's expression platforms for recombinant protein manufacturing have been optimised for...
Webinar (on-demand)
Transfer and Development of Mammalian Processes: Effective technology transfer for mammalian derived...
Translating innovations from research laboratories to clinical and commercial manufacturing is a...
Article
Tools for Developing Successful Biologics - XS Pichia® Expression System
Lonza subject matter experts talk about the XS® Pichia Expression System and how it could benefit...
Article
Successfully Transitioning mRNA Production to cGMP Requires Early Process Engagement for Developing...
Discover why early process optimization is key to developing an efficient, cost-effective cGMP...
Technical/Service brief
XS Technologies® Microbial Platform for Protein Expression Brochure
XS Technologies® are the microbial expression systems for today’s therapeutics. While...
Presentation (on-demand)
The CDMO Value Proposition of Experience for Your Autologous Cell Therapy
As the lead partner for CAR-TCR 2023, we were thrilled to deliver the opening plenary session,...
Previous
Next